Science and Enterprise

Category: Joint ventures/collaborations

  • Biotech Makes Available Stem Cell Lines to Researchers

    BioTime Inc., a biotechnology company in Alameda, California said today it concluded an agreement to make five research-grade human embryonic stem (hES) cell lines available to University of California (UC) system researchers. These lines are genetically identical to the Good Management Practice (GMP)-compliant hES cell lines that will be made available to researchers in California…

  • Nanosatellites Launched in SpaceX Falcon Vehicle

    Among the payloads in the commercial Space Exploration (SpaceX) Technologies Inc., Falcon 9 vehicle, launched into low-earth orbit on 8 December were two two small satellites, called nanosatellites, built by the U.S. Naval Research Lab. The lab, part of the Department of Defense,  says the launch of these satellites will help evaluate their utility  for…

  • Biotech Inks Three New Drug Discovery Deals

    Adimab Inc., a biotechnology company in Lebanon, New Hampshire today announced three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. The company offers a technology platform for the discovery of human antibodies. For Eli Lilly, Adimab will use its discovery platform to identify fully human antibodies against two targets selected by…

  • Health Care Systems to Share Practices on Quality, Costs

    Six health care systems in the U.S. announced today a collaboration to improve health care quality while reducing costs. Participating organizations — representing networks of hospitals, clinicians, and researchers — include Dartmouth-Hitchcock, Cleveland Clinic, Denver Health, Geisinger Health System, Intermountain Healthcare, and Mayo Clinic. The Collaborative, as it is called, promises to share data on…

  • Collaboration to Develop Smart Power Grid in Denmark

    A collection of 32 partners — companies, not-for-profits, research institutes, and universities — have agreed to develop a new intelligent power grid in Denmark. Called the iPower platform, the new system aims to be ready in 2025, when Denmark is scheduled to generate half of its electricity from wind energy. The iPower platform’s full name…

  • Israeli Prof. Develops Catalysts for Biodegradable Plastics

    Moshe Kol, professor chemistry at Tel Aviv University in Israel, is developing new processes using corn starch and sugar to make biodegradable plastics more competitive in the industry. Kol’s approach involves a new variety of catalysts, substances that initiate or sustain chemical reactions in other substances. Kol’s team in Tel Aviv is working with collaborators…

  • Collaboration Researching Vaccine Against Malaria Parasite

    The PATH Malaria Vaccine Initiative, Merck & Co. in Whitehouse Station, New Jersey, and NYU Langone Medical Center in New York are working on a new approach targeting a part of a major surface protein on the malaria parasite. The goal of the joint project is to develop a vaccine to prevent the malaria parasite…

  • Weather Company, Brazil Institute to Test Lightning Sensors

    WeatherBug, a Germantown, Maryland provider of weather-related products and services and operator of a weather observation network, has agreed to form a research partnership with the Instituto Nacional de Pesquisas Espaciais (INPE), Brazil’s National Institute for Space Research. WeatherBug and INPE will collaborate on research to test the performance of a network of 12 WeatherBug…

  • Journal Highlights African Health Innovations

    A supplement to the open-access journal BMC International Health and Human Rights devotes its entire issue to health innovations in sub-Saharan Africa, which offers case studies of local initiatives. The papers, relating the experiences of projects by institutes and companies in Ghana, Kenya, Madagascar, Nigeria, Rwanda, South Africa, Tanzania, and Uganda provide lessons from successful…

  • U.S. Biotech, Japanese Pharma Partner on Protein Drugs

    Anaphore Inc. of La Jolla, California and Mitsubishi Tanabe Pharma Corporation in Osaka, Japan formed a partnership for research, development, and commercialization of protein therapies for autoimmune disease. The partnership will focus on disorders such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. The companies will make use of Anaphore’s technology, which generates novel trivalent…